Cholrem study shows cyclodextrin-based therapy Cavadex reverses atherosclerotic cardiovascular…
Peer-reviewed research in Cardiology Research and Cardiovascular Medicine reports regression of arterial plaque and symptom relief…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
CCRAS and WHO-SEARO conduct regional workshop on WHO-GMP for herbal medicines in Mumbai
Four-day workshop from 19–22 August 2025 brings together international delegates and Indian experts to discuss good manufacturing…
Valkit.ai announces strategic partnership with Life Science Consulting
Generation 2 digital validation platform expands global reach through alliance with 25-year industry leader serving 200+…
Alembic Pharmaceuticals receives USFDA approval for Macitentan Tablets, 10 mg
Alembic Pharmaceuticals secures final approval for its ANDA Macitentan Tablets, a therapeutic equivalent of Actelion’s Opsumit,…
HiMedia Laboratories receives CDSCO approval for Hepatitis B and C Molecular Diagnostic Kits
The Hi-PCR® Hepatitis B and C detection and quantitation kits will now be manufactured in India under CDSCO approval, supporting…
Alkem Laboratories launches Olesoft Trucera moisturising lotion to strengthen skin barrier
Olesoft Trucera contains ceramides, N-Palmitoyl Serinol, dual oat-extract actives and Niacinamide; available on prescription…
Disruption to traditional distribution channels to hinder pharma companies from adopting Trump’s DTC…
GlobalData highlights patient awareness gaps, operational demands, and disrupted supply chains as key barriers to US pharma…
BRAND GMBH + CO KG launches Transferpette pro micropipette in India
The new Transferpette® pro expands the Transferpette S lineup with added flexibility, user adjustment features, and broader volume…
DKMS opens applications for 2026 John Hansen Research Grant in stem cell transplantation and cell…
Up to four young scientists will receive €240,000 each over three years for research on haematopoietic stem cell transplantation…
Glenmark Pharmaceuticals to launch Micafungin for Injection USP in the United States
The company will distribute Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial), beginning September 2025
Reshaping healthcare: The convergence of digital therapeutics and point-of-care diagnostics
As digital tools evolve, the integration of Digital Therapeutics and Point-of-Care diagnostics is transforming how care is…
Bladder cancer market to reach $16 billion in 8MM in 2033, forecasts GlobalData
Therapeutic innovation, including antibody-drug conjugates, sustained-release systems, and gene therapies, is driving rapid growth…
Danone India and Maharashtra Government conduct health camps in Mumbai to address iron deficiency in…
Health camps in Govandi and Dharavi screened children aged 2 to 6 years for iron deficiency anaemia and promoted awareness on…
Amansa Investments completes ₹250 crore pre-IPO placement in Rubicon Research
The investment reduces Rubicon Research’s fresh IPO issue size to ₹250 crore, with General Atlantic Singapore RR Pte retaining…
CRISPR-based therapeutics hold potential to combat AMR and cure chronic viral infections: GlobalData
GlobalData report explores clinical progress, market trends, and regulatory developments shaping CRISPR-based therapies for…
Goa to introduce pricing policy for innovative lifesaving therapies
State to be reportedly first in India to implement outcome-linked pricing for advanced treatments, beginning with lung cancer
Government of India to host Bharat NutraVerse Expo 2025
Government of India, through SHEFEXIL, to bring global nutraceutical leaders together in New Delhi from 4–6 September 2025 to…
Greenspace Herbs unveils Quantum Ayurveda technology platform
The business has mapped 25,000 bioactive signatures and is currently working on 150,000 more
Lilly launches Mounjaro KwikPen (tirzepatide) in India
The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquisition will be funded through the IPO proceeds raised by Senores. This is in line with the Objects of the IPO stated in…